Does DOFETILIDE Cause Neoplasm malignant? 27 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Neoplasm malignant have been filed in association with DOFETILIDE (Dofetilide). This represents 0.5% of all adverse event reports for DOFETILIDE.
27
Reports of Neoplasm malignant with DOFETILIDE
0.5%
of all DOFETILIDE reports
5
Deaths
8
Hospitalizations
How Dangerous Is Neoplasm malignant From DOFETILIDE?
Of the 27 reports, 5 (18.5%) resulted in death, 8 (29.6%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOFETILIDE. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does DOFETILIDE Cause?
Drug ineffective (654)
Atrial fibrillation (438)
Death (285)
Electrocardiogram qt prolonged (267)
Dyspnoea (230)
Dizziness (228)
Fatigue (180)
Malaise (175)
Headache (154)
Palpitations (128)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DOFETILIDE Alternatives Have Lower Neoplasm malignant Risk?
DOFETILIDE vs DOLUTEGRAVIR
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOFETILIDE vs DOLUTEGRAVIR\RILPIVIRINE
DOFETILIDE vs DOMPERIDONE